Cephalon Sues Apotex To Block Generic Nuvigil
Apotex infringed the two patents by submitting an abbreviated new drug application to make and sell the Nuvigil generic armodafinil to the U.S. Food and Drug Administration, according to a complaint filed Thursday in the U.S. District Court for the Southern District of Florida.
The patents-in-suit are U.S....
Already a subscriber? Click here to login